Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|February 22, 2014
CRISPR-Cas-mediated targeted genome editing in human cellsLuhan Yang, Prashant Mali, Caroline Kim-Kiselak, et al.Annals of Surgical Oncology|June 13, 2021
Gastric Neuroendocrine Tumors: Reappraisal of Type in Predicting OutcomeAndrew Hanna, Caroline Kim-Kiselak, Rebecca Tang, et al.Cancer Discovery|April 18, 2014
Obligate progression precedes lung adenocarcinoma disseminationDeborah R Caswell, Chen-Hua Chuang, Dian Yang, et al.Genes & Development|July 23, 2013
Differential Tks5 isoform expression contributes to metastatic invasion of lung adenocarcinomaCarman Man-Chung Li, Guoan Chen, Talya L Dayton, et al.Cancer Research|February 17, 2017
Systematic In Vivo Inactivation of Chromatin-Regulating Enzymes Identifies Setd2 as a Potent Tumor Suppressor in Lung AdenocarcinomaDavid M Walter, Olivia S Venancio, Elizabeth L Buza, et al.Cell Reports|June 17, 2014
A conditional system to specifically link disruption of protein-coding function with reporter expression in miceShin-Heng Chiou, Caroline Kim-Kiselak, Viviana I Risca, et al.Nucleic Acids Research|August 3, 2013
Optimization of scarless human stem cell genome editingLuhan Yang, Marc Guell, Susan Byrne, et al.Nature|May 3, 2019
RB constrains lineage fidelity and multiple stages of tumour progression and metastasisDavid M Walter, Travis J Yates, Miguel Ruiz-Torres, et al.Proceedings of the National Academy of Sciences of the United States of America|June 28, 2017
Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survivalVasilena Gocheva, Alexandra Naba, Arjun Bhutkar, et al.Proceedings of the National Academy of Sciences of the United States of America|October 6, 2016
Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinomaDavid G McFadden, Katerina Politi, Arjun Bhutkar, et al.Pageof 2